Who invested in Profectus Biosciences?
Profectus Biosciences's investors include Cross Atlantic Capital Partners.
United States · Funded startup
7 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$42Mraised across 7 rounds since 2007, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $7.5M sold, first sale Jul 2009
From a historical funding recordSEC filing: $7.3M sold, first sale Jul 2009
No investor was named in the report.
Reported by sec.govSEC filing: $7.0M sold, first sale Jul 2009
Reported by baltimore.bizjournals.comSEC filing: $5.0M sold, first sale Jul 2009
Profectus Biosciences's investors include Cross Atlantic Capital Partners.
Profectus Biosciences has raised $42M across 7 rounds since 2007.
Profectus Biosciences's most recent round was a Grant of $9.5M in Oct 2014.
Its most recent round, $9.5M in Oct 2014, is also its largest on record.
Profectus Biosciences's first round on record, in Jun 2007, was backed by Cross Atlantic Capital Partners.
Profectus Biosciences's latest named round is a Grant, in Oct 2014.
Profectus Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.